言語を選択
新規登録

CD64A

お問い合わせ

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
CusatuzumabARGX-110; JNJ-4550Phase 2 ClinicalArgenx SeMyelodysplastic Syndromes; Neoplasms; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute
詳細
PRO-1160PRO-1160Phase 2 ClinicalProfoundBio (Suzhou) Co LtdSolid tumours; Carcinoma, Renal Cell; Nasopharyngeal Carcinoma; Lymphoma; Lymphoma, Non-Hodgkin
詳細
CD70 Targeted CAR-T Cells Therapy(UTC Therapeutics)Phase 2 ClinicalUTC Therapeutics IncSolid tumours; Urologic Neoplasms; Lymphoma
詳細
Cord Blood-derived CAR NK Cells Targeting CD19/CD70(Shanghai Tongji Hospital)Phase 2 ClinicalShanghai Tongji HospitalLymphoma, B-Cell
詳細
MP0533MP0533Phase 2 ClinicalMolecular Partners AgLeukemia, Myeloid, Acute
詳細
GD2/CD70 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)bi-4SCAR GD2/CD70Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteNeoplasms
詳細
CD19/70 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteLymphoma, B-Cell; Leukemia, B-Cell
詳細
PSMA/CD70 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)bi-4SCAR PSMA/CD70Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteNeoplasms
詳細
SEA-CD70SEA-CD70Phase 1 ClinicalMyelodysplastic Syndromes; Leukemia, Myeloid, Acute
詳細
BR-108BR-108Phase 1 ClinicalBioRay Pharmaceutical Co LtdHematologic Neoplasms; Leukemia
詳細
ARX-305ARX-305; NCB-002Phase 1 ClinicalNeoplasms
詳細
CD70-CAR-NK Cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine)Phase 1 ClinicalSecond Affiliated Hospital School Of Zhejiang University School Of MedicineLeukemia, Myeloid, Acute; Lymphoma, T-Cell
詳細
Chimeric Antigen Recertor Treatment Targeting CD70(Baylor College of Medicine)Phase 1 ClinicalBaylor College Of MedicineLeukemia, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Leukemia, T-Cell
詳細
CAR T-cell Therapy Directed to CD70(St Jude Children's Research Hospital)Phase 1 ClinicalSt. Jude Children'S Research HospitalHematologic Neoplasms; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Lymphoma
詳細
CD70-CART（Hrain）HR010; HR-010Phase 1 ClinicalHrain Biotechnology Co LtdCarcinoma, Renal Cell
詳細
Anti-CD19/CD70 NK cell therapy (Zhejiang University)Phase 1 ClinicalZhejiang UniversityLymphoma, Non-Hodgkin
詳細
CD70 CAR-T cell therapy (Chongqing Precision Biotech)Phase 1 ClinicalChongqing Precision Biotechnology Co LtdSolid tumours; Ovarian Neoplasms; Carcinoma, Renal Cell; Neoplasms; Genital Neoplasms, Female; Uterine Cervical Neoplasms; Neoplasm Metastasis
詳細
CTX-130CTX-130Phase 1 ClinicalCrispr Therapeutics AgCarcinoma, Renal Cell; Lymphoma, T-Cell
詳細
IMM-40HIMM-40H; IMM40HPhase 1 ClinicalImmuneOnco Biopharmaceuticals (Shanghai) Co LtdHematologic Neoplasms; Solid tumours; Neoplasms
詳細
ALLO-316ALLO-316Phase 1 ClinicalCellectis SaCarcinoma, Renal Cell
詳細
C-4-29Phase 1 ClinicalChongqing Precision Biotechnology Co LtdCarcinoma, Renal Cell; Multiple Myeloma
詳細
CD70-targeted CAR-NKT Cells Therapy(Cure Genetics Biosciences)CGC738; CGC-738ClinicalSuzhou Cure Genetics Biosciences Co LtdCarcinoma, Renal Cell
詳細
  • お問い合わせ
  • 治験薬に関する情報
共有：

採用情報法的規制サイトマッププライバシーポリシー利用規約
ウェブサイトに関するフィードバック
お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8